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The purpose of muscle relaxants is to provide muscular relaxation by selective Autonomic Effects. The autonomic effects of muscle relaxants are also due to competition with acetylcholine for the cholinergic receptors of the autonomic ganglia. After their adsorbtion to these receptors, they may either inhibit or facilitate the transmission of ganglionic impulses. d-Tubocurarine has the most marked autonomic effect of the relaxants in current clinical use. The ganglionic effects of other relaxants are restricted to certain components of the autonomic nervous system. For example, gallamine has a selective inhibitory effect on the cardiac vagus and benzoquinonium in clinical doses stimulates, and in larger doses inhibits, the vagus.
Respiratory Effects. Muscle relaxants may influence respiration by paralysing respiratory muscles, by depressing the activity of the respiratory centre, and by bronchoconstriction caused by histamine release.'7 The sensitivity of the diaphragm to relaxants is usually less than that of other muscles. Bronchoconstriction caused by histamine release has been observed only with d-tubocurarine.
Circulatory Effects. In clinical doses the muscle relaxants have no appreciable effect on cardiac muscle. The circulatory effects of the relaxants are related to their autonomic effects and their histamine releasing properties, and are manifested by changes in heart rate and blood pressure. Gallamine may cause acceleration of the heart with moderate rise in blood pressure; benzoquinonium may decrease the heart rate. d-Tubocurarine, by inhibiting the sympathetic vasoconstrictors and liberating histamine, occasionally causes hypotension. The elevation of blood pressure seen after large doses of succinylcholine, or after relaxant doses in light anaesthesia, is probably due to its stimulating effect on the sympathetic system. 
